Domingo Rodriguez-Cue, MD
Family Medicine · Garner, NCNPI 1942263181
Payments from drug & device makers
Across 648 payments — averaging $390.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$119K
- Harmony Biosciences LLC$55K
- Inspire Medical Systems, Inc.$25K
- Axsome Therapeutics, Inc.$23K
- Avadel CNS Pharmaceuticals, LLC$16K
- Jazz Pharmaceuticals Inc.$11K
- plus $4K from 12 others
Across 3 payments — averaging $3528.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Idorsia Pharmaceuticals US Inc$8K
- Ensodata, Inc.$3K
What the payments were for
- Consulting fees$65,71526%
- Speaking & faculty fees$152,90560%
- Travel & lodging$15,3356%
- Food & beverage$18,1977%
- Education$9000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 163 | $118,589 |
| Harmony Biosciences LLC | 191 | $55,233 |
| Inspire Medical Systems, Inc. | 32 | $24,709 |
| Axsome Therapeutics, Inc. | 71 | $22,599 |
| Avadel CNS Pharmaceuticals, LLC | 31 | $16,484 |
| Jazz Pharmaceuticals Inc. | 92 | $11,158 |
| Resmed Corp | 44 | $2,562 |
| ZOLL Respicardia, Inc. | 5 | $801 |
| Somnomed Inc. | 1 | $192 |
| Novo Nordisk | 3 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $149 |
| Vatech America, Inc. | 1 | $108 |
| Noctrix Health, Inc. | 1 | $84 |
| Mitsui Chemicals, Inc. | 1 | $74 |
| Lilly USA, LLC | 3 | $45 |
| Eisai Inc. | 3 | $44 |
| Fisher & Paykel Healthcare Inc | 2 | $42 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$253,052 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 64 | $744,423 |
| LumryzSodium Oxybate | 15 | $123,930 |
| SunosiSolriamfetol Hcl | 71 | $63,025 |
| BelsomraSuvorexant | 48 | $23,294 |
| HorizantGabapentin Enacarbil | 21 | $13,926 |
| NeuproRotigotine | 14 | $11,788 |
| QuviviqDaridorexant Hcl | 14 | $6,955 |
| Armodafinil | 94 | $5,190 |
| Modafinil | 49 | $1,574 |
| Famotidine | 98 | $1,325 |
| Eszopiclone | 73 | $1,182 |
| Gabapentin | 72 | $1,094 |
| Ropinirole Hcl | 49 | $784 |
| Methylphenidate Hcl | 22 | $715 |
| Ropinirole ErRopinirole Hcl | 13 | $706 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $55,233 | $744,42364 claims |
| Avadel CNS Pharmaceuticals, LLCLumryz | $16,484 | $123,93015 claims |
| Axsome Therapeutics, Inc.Sunosi | $22,599 | $63,02571 claims |
| MerckBelsomra | $13 | $23,29448 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $118,589 | $6,95514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Garner
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.